Review
Open access
Aug 2026
Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions
It is concluded that targeting tumor immunosenescence represents a promising but incompletely validated therapeutic axis for enhancing anti-tumor immunity in breast cancer.
Qing Lei, Xue-Jun Guo
· Frontiers in Oncology · 0 citations